SAN JOSE, Calif., Jan. 9, 2012 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) today announced Invisalign Express 5, a cost-effective treatment option for very minor crowding, spacing, or orthodontic relapse treatments requiring five or fewer stages of Invisalign aligners. Invisalign Express 5 will help doctors treat more patients who could benefit from minor tooth movements, but are reluctant to invest in treatment due to cost.

Invisalign Express 5 offers the same high-quality features that doctors expect from other Invisalign treatment options, including:

• ClinCheck treatment plan that shows a 3-D virtual representation of the desired final result and the number of aligner stages required;
• SmartForce^® attachments and aligner features engineered to deliver force systems for predictable tooth movements;
• An optional one-time refinement of up to five aligners to help achieve the final tooth position as defined in the original ClinCheck treatment plan.

"Many patients want to correct a little crowding or other minor malocclusions, but don't follow-through because of the perceived high cost of orthodontic treatment," said Timothy A. Mack, Align senior vice president, business development. "Invisalign Express 5 gives doctors a new option for these patients — one with all the benefits of Invisalign and straighter teeth at a price consistent with minor fixes."

Invisalign Express 5 is a shorter-duration option to Invisalign Express 10, Align's treatment option for minor crowding, spacing, or pre-restorative treatments that can be addressed in 10 or fewer stages of aligners. Invisalign Express 5 will be available beginning January 30 to Invisalign doctors in North America at a lab fee of $549 with the optional one-time refinement for an additional lab fee of $125. For more information, please visit www.AligntechInstitute.com.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.The Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express 10, Invisalign Express 5, and Vivera Retainers.

To learn more about Invisalign or to find an Invisalign trained doctor in your area, please visit www.invisalign.com.

Cadent Holdings, Inc. is a subsidiary of Align Technology and is a leading provider of 3D digital scanning solutions for orthodontics and dentistry. The Cadent family of products includes iTero and iOC scanning systems, OrthoCAD iCast, OrthoCAD iQ and OrthoCAD iRecord. For additional information, please visit www.itero.com.  

CONTACT: Investor Relations Contact

         Shirley Stacy

         Align Technology, Inc.

         (408) 470-1150

         sstacy@aligntech.com

         

         Press Contact

         Shannon Mangum Henderson

         Ethos Communication, Inc.

         (678) 261-7803

         align@ethoscommunication.com